Analytic Investors’s Braskem BAK Stock Holding History

Analytic Investors’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-44,850	Closed	-$531K	–	592
2016 Q2	$531K	Buy	+44,850	New	+$558K	0.01%	470

Other funds holding BAK

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GFM

Gramercy Funds Management Greenwich, Connecticut $6.07M AUM 35.69% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Analytic Investors's BAK Position: Q3 2016 in Review

Analytic Investors sold out of Braskem (BAK) in Q3 2016, closing a stake of 44,850 shares — an estimated $531K sold.

Analytic Investors first reported a position in BAK in Q2 2016 and held it in 1 quarter. The position peaked at $531K in Q2 2016. 83 funds tracked by Wall St. Rank hold BAK as of Q3 2016.

Analytic Investors reported no remaining Braskem position as of Q3 2016 after selling out during the quarter.
Analytic Investors sold 44,850 Braskem shares in Q3 2016, an estimated $531K.
Analytic Investors first reported a position in Braskem in Q2 2016 and held it in 1 quarter.
Analytic Investors's Braskem position peaked at $531K in Q2 2016.
83 funds tracked by Wall St. Rank held Braskem as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.